Assessing HER2 status in breast cancer through next-generation sequencing of circulating tumor cells.
Serena Di CosimoMarco SilvestriCinzia De MarcoCarolina ReduzziSecondo FolliMaria Carmen De SantisVera CappellettiPublished in: The International journal of biological markers (2024)